Subject
Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy
Reference17 articles.
1. Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar;Chemaitelly;N Engl J Med,2021
2. COVID-19 vaccine use in immunocompromised patients: a commentary on evidence and recommendations;Duly;Am J Health Syst Pharm,2022
3. City of Toronto. COVID-19: vaccine eligibility & doses. 2021. Available at: https://www.toronto.ca/community-people/health-wellness-care/health-programs-advice/respiratory-viruses/covid-19/covid-19-vaccines/covid-19-vaccine-eligibility-doses/ Accessed May 15, 2023.
4. Outcome of COVID-19 in allogeneic stem cell transplant recipients: results from the EPICOVIDEHA registry;Busca;Front Immunol,2023
5. Safety and immunogenicity after a three-dose SARS-CoV-2 vaccine schedule in allogeneic stem cell transplant recipients;Kimura;Transplant Cell Ther,2022